Follow
Eurocine Vaccines AB
Spotlight (Sweden)
Eurocine Vaccines is a pharmaceutical company. The Company develops vaccines by using its proprietory technology platform Endocine™, vaccines which later are licensed to partners for further development and commercialization. The development is conducted together with other companies in the industry. The technology platform Endocine™ can also be offered to other companies for development within specific indications. The head office is located in Solna and Eurocine Vaccines is listed at Spotlight Stockmarke Eurocine Vaccines is a pharmaceutical company. The Company develops vaccines by using its proprietory technology platform Endocine™, vaccines which later are licensed to partners for further development and commercialization. The development is conducted together with other companies in the industry. The technology platform Endocine™ can also be offered to other companies for development within specific indications. The head office is located in Solna and Eurocine Vaccines is listed at Spotlight Stockmarket.

Read more

Sector:
HEALTH CARE
>
Pharmaceuticals
Pharmaceuticals, Biotechnology & Life Sciences
Current instruments
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0001839069
Spotlight
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Active
Order book id
4102
Amount of instruments
789 541 214
Par value
0.0025
Market cap
85 300 000.00 SEK
Currency
SEK
First trading date
11 Dec 2006
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
4.80 SEK
13.68M SEK
16 Oct - 13 Nov 2006
IPO in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
16.00 SEK
108.32M SEK
11 Oct - 26 Oct 2007
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
23.00 SEK
194.6M SEK
19 Feb - 05 Mar 2010
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
19.00 SEK
168.8M SEK
17 Jan - 31 Jan 2011
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
17.00 SEK
180M SEK
01 Jun - 15 Jun 2012
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
6.50 SEK
77.3M SEK
11 Feb 2014
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.65 SEK
35M SEK
14 Apr - 28 Apr 2015
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.10 SEK
24M SEK
25 Feb - 09 Mar 2016
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Exercise
2.34 SEK
151.71M SEK
17 Oct - 28 Oct 2016
Option exercise terms for EUCI TO 1
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.34 SEK
125.1M SEK
28 Nov - 12 Dec 2017
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Exercise
0.24 SEK
16.3M SEK
26 Nov - 07 Dec 2018
Option exercise terms for EUCI TO 2
Type
Price
Pre-money valuation
Time
Files
Targeted issue
0.24 SEK
17.1M SEK
20 Dec 2018
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.11 SEK
9.4M SEK
25 Mar - 08 Apr 2019
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Private placement
0.1187 SEK
25.2M SEK
14 Oct 2019
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.053 SEK
12.3M SEK
21 Jan - 04 Feb 2020
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Exercise
0.087 SEK
61.3M SEK
01 Jun - 12 Jun 2020
Option exercise terms for EUCI TO 3
Type
Ticker
ISIN
Market
SHARE
EUCI
SE0001839069
Spotlight
Sweden (SE)
Details of share in Eurocine Vaccines AB with ticker EUCI
Status
Active
Order book id
4102
Amount of instruments
789 541 214
Par value
0.0025
Market cap
85 300 000.00 SEK
Currency
SEK
First trading date
11 Dec 2006
Terms
Type
Price
Pre-money valuation
Time
Files
IPO
4.80 SEK
13.68M SEK
16 Oct - 13 Nov 2006
IPO in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
16.00 SEK
108.32M SEK
11 Oct - 26 Oct 2007
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
23.00 SEK
194.6M SEK
19 Feb - 05 Mar 2010
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
19.00 SEK
168.8M SEK
17 Jan - 31 Jan 2011
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
17.00 SEK
180M SEK
01 Jun - 15 Jun 2012
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
6.50 SEK
77.3M SEK
11 Feb 2014
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.65 SEK
35M SEK
14 Apr - 28 Apr 2015
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
1.10 SEK
24M SEK
25 Feb - 09 Mar 2016
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
2.34 SEK
125.1M SEK
28 Nov - 12 Dec 2017
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Targeted issue
0.24 SEK
17.1M SEK
20 Dec 2018
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.11 SEK
9.4M SEK
25 Mar - 08 Apr 2019
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Private placement
0.1187 SEK
25.2M SEK
14 Oct 2019
Share issue in Eurocine Vaccines AB
Type
Price
Pre-money valuation
Time
Files
Rights issue
0.053 SEK
12.3M SEK
21 Jan - 04 Feb 2020
Share issue in Eurocine Vaccines AB
Type
Ticker
ISIN
Market
OPTION
EUCI TO 1
SE0008092555
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 1
Status
Archived
Order book id
121659
Amount of instruments
16 344 885
Market cap
Currency
SEK
Trading period
02 May 2016 - 26 Oct 2016
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price per share corresponding to 70% of the volume weighted average of the stock price for the company's share during the period 03.10.2016-14.10.2016.
Update (17.10.2016): Eurocine Vaccines initiates the exercise of warrants at the price of SEK 2.34
Update (21.10.2016): Last day for trading with warrant TO1 in Eurocine Vaccines AB is October 26, 2016.
Type
Price
Pre-money valuation
Time
Files
Exercise
2.34 SEK
151.71M SEK
17 Oct - 28 Oct 2016
Option exercise terms for EUCI TO 1
Type
Ticker
ISIN
Market
OPTION
EUCI TO 2
SE0010599878
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 2
Status
Archived
Order book id
4683
Amount of instruments
14 015 388
Market cap
Currency
SEK
Trading period
31 Jan 2018 - 05 Dec 2018
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the company at a subscription price per share corresponding to 70% of the volume weighted average of the stock price for the company's share during the period 12-23 November 2018. However, with reference to current legislation, the subscription price may not be lower than the share's quota value at the time. for share subscription. Subscription with the support of the warrants will take place during the period 26 November - 7 December 2018.
Update (24.01.2018): Trading in warrants series TO 2 will commence on 31 January 2018.
Update (26.11.2018): The subscription price has been calculated at SEK 0.24 per share.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.24 SEK
16.3M SEK
26 Nov - 07 Dec 2018
Option exercise terms for EUCI TO 2
Type
Ticker
ISIN
Market
OPTION
EUCI TO 3
SE0013668258
Spotlight
Sweden (SE)
Details of option in Eurocine Vaccines AB with ticker EUCI TO 3
Status
Archived
Order book id
5XU4
Amount of instruments
278 777 940
Market cap
Currency
SEK
Trading period
04 Mar 2020 - 12 Jun 2020
Terms
One warrant of the series TO3 entitles to subscribe for a new share in Eurocine Vaccines. The subscription price amounts to seventy (70) percent of the average volume-weighted price for the share according to Spotlight Stock Market's official price statistics for the period of 10 trading days ending before the exercise period begins. The company will publish the subscription price the day before the first day of the exercise period. The subscription price must not be less than the share's quota value at the time of the subscription.
Update (26.05.2020): Eurocine Vaccines has agreed on subscription links and guarantee subscriptions corresponding to approximately 28 percent of the issue volume for TO3.
Update (29.05.2020): Eurocine Vaccines announces subscription price for the exercise period for subscription options of series TO 3.
Update (10.06.2020): The last day for exercise of warrants of the TO 3 series in Eurocine Vaccines is June 12, 2020.
Type
Price
Pre-money valuation
Time
Files
Exercise
0.087 SEK
61.3M SEK
01 Jun - 12 Jun 2020
Option exercise terms for EUCI TO 3
People
Hans Arwidsson
CEO
Pierre Morgon
Chairman of the board
Hans Arwidsson
Board member
Emanuele Montomoli
Board member
Jan Sandström
Board member
Pär Thuresson
Board member
Company Details
Sector
HEALTH CARE

Address
Fogdevreten 2
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
556566-4298
LEI code
549300B408R6FTXR0D15
First trade date
11 Dec 2006
Registration date
15 Feb 1999
Short name
Eurocine Vaccines

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More

Create Your FREE Account to stay Up To Date